Nanocarriers made from non-ionic surfactants or natural polymers for pulmonary drug delivery.

Katharine Carter, Mireia Puig

Research output: Contribution to journalArticle

Abstract

Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.
LanguageEnglish
Number of pages28
JournalCurrent Pharmaceutical Design
Publication statusAccepted/In press - 6 Dec 2015

Fingerprint

Surface-Active Agents
Polymers
Lung
Pharmaceutical Preparations
Drug Delivery Systems
Biological Products
Chronic Obstructive Pulmonary Disease
Polysaccharides
Lung Neoplasms
Asthma
Therapeutics
Proteins

Keywords

  • drug delivery systems
  • non-ionic surfactant vesicles
  • nanoparticles
  • pulmonary

Cite this

@article{3e25285c7ee64d04b48ec4cf1ecdb521,
title = "Nanocarriers made from non-ionic surfactants or natural polymers for pulmonary drug delivery.",
abstract = "Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.",
keywords = "drug delivery systems, non-ionic surfactant vesicles, nanoparticles, pulmonary",
author = "Katharine Carter and Mireia Puig",
year = "2015",
month = "12",
day = "6",
language = "English",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",

}

TY - JOUR

T1 - Nanocarriers made from non-ionic surfactants or natural polymers for pulmonary drug delivery.

AU - Carter, Katharine

AU - Puig, Mireia

PY - 2015/12/6

Y1 - 2015/12/6

N2 - Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.

AB - Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.

KW - drug delivery systems

KW - non-ionic surfactant vesicles

KW - nanoparticles

KW - pulmonary

UR - http://benthamscience.com/journals/current-pharmaceutical-design/

M3 - Article

JO - Current Pharmaceutical Design

T2 - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

ER -